NBY
NovaBay Pharmaceuticals (NBY)
$53
About NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.
Details
Daily high
$0.53
Daily low
$0.50
Price at open
$0.50
52 Week High
$9.08
52 Week Low
$0.36
Market cap
2.6M
Dividend yield
0.00%
Volume
597,911
Avg. volume
114,807
P/E ratio
-.01
NovaBay Pharmaceuticals News
Details
Daily high
$0.53
Daily low
$0.50
Price at open
$0.50
52 Week High
$9.08
52 Week Low
$0.36
Market cap
2.6M
Dividend yield
0.00%
Volume
597,911
Avg. volume
114,807
P/E ratio
-.01